Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Mutuum Finance (MUTM) Approaches $20M Funding as Q4 V1 Launch Prep Intensifies with Halborn Security

December 13, 2025

William Sandeson’s appeal of murder conviction dismissed by Nova Scotia court

December 13, 2025

Decade-long analysis looks at domestic homicide rates in Atlantic provinces

December 13, 2025

Princeton, B.C. under flood watch as Tulameen, Similkameen rise amid atmospheric river

December 13, 2025

Kelowna boasts highest vacancy rate of any Canadian metropolitan area

December 12, 2025
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » SuspendIt® Is Now a USP Verified Excipient
Press Release

SuspendIt® Is Now a USP Verified Excipient

By News RoomDecember 10, 20252 Mins Read
SuspendIt® Is Now a USP Verified Excipient
Share
Facebook Twitter LinkedIn Pinterest Email
SuspendIt® Is Now a USP Verified Excipient

Houston, TX, Dec. 10, 2025 (GLOBE NEWSWIRE) — PCCA, a leading supplier of pharmaceutical ingredients, announced today the U.S. Pharmacopeia (USP) has verified SuspendIt® — adding to its growing family of proprietary compounding bases that have earned this independent mark of quality assurance. Earlier this year, PCCA became the first FDA-registered supplier to complete the USP Ingredient Verification Program for Excipients for compounding bases, receiving verification for its LoxOral® and Anhydrous SuspendIt® bases.

“This verification demonstrates our continued commitment to our ‘Quality without Compromise’ core value,” said PCCA CEO Gus Bassani, PharmD. “Confirmation of quality through independent verification reinforces our promise to pharmacies and patients to deliver purity and consistency with our products. Our goal is to help our members compound with confidence.”

PCCA’s third USP Verified Excipient, SuspendIt®, is an all-in-one, aqueous compounding base that is specifically designed for oral suspension formulations. With its innovative technology, SuspendIt® enables rapid redispersion of APIs with gentle agitation, reduces sedimentation and helps support consistent dosing. Free of gluten, alcohol, parabens and dyes, SuspendIt® is suitable for a wide range of patients with sensitivity concerns.

“We are investing our time and efforts into completing the USP Verification process to verify the quality of our bases, even though regulations do not require it,” Bassani said. “We plan to continue pursuing this verification for additional PCCA proprietary bases.”

PCCA invests heavily in research and development to create unique, patented bases to enhance therapeutic outcomes, while providing independent compounding pharmacies and health systems with quality products, expert guidance and innovative approaches to delivering personalized medicine.

ABOUT PCCA
PCCA supports the creation of personalized medicine and innovative products that make a difference in patients’ lives. As a complete resource for independent compounding pharmacies and health systems, PCCA provides high-quality products, education and support to more than 3,000 pharmacy members throughout the United States, Canada, Australia and other countries around the world. Incorporated in 1981 by a network of pharmacists, PCCA has supported pharmacy compounding for more than 40 years. Learn more at pccarx.com.

  • SuspendIt® Is Now a USP Verified Excipient

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Mutuum Finance (MUTM) Approaches $20M Funding as Q4 V1 Launch Prep Intensifies with Halborn Security

Milestone Receives FDA Approval of CARDAMYST™ (etripamil) as First and Only Self-Administered Nasal Spray for Adults with Paroxysmal Supraventricular Tachycardia (PSVT)

Alameda Health System reminds community: Apply for Medi-Cal before December 31, 2025

GeeFi Announces Major Community Giveaway to Celebrate Presale Success

Billor for Brokers Strengthens Specialized Freight Capacity with Live Bee Hauling Operations

GeeFi (GEE) Launches High-Reward Referral Program to Accelerate Community Growth

NurExone Plans Small-Scale of ExoPTEN Clinical Manufacturing in Preparation for FUTURE First in Human USE Pathways

Park Dental Partners Rings the Closing Bell on the Nasdaq in New York

Alpine Bank celebrates the enduring legacy of Founder J. Robert “Bob” Young

Editors Picks

William Sandeson’s appeal of murder conviction dismissed by Nova Scotia court

December 13, 2025

Decade-long analysis looks at domestic homicide rates in Atlantic provinces

December 13, 2025

Princeton, B.C. under flood watch as Tulameen, Similkameen rise amid atmospheric river

December 13, 2025

Kelowna boasts highest vacancy rate of any Canadian metropolitan area

December 12, 2025

Subscribe to News

Get the latest Canada news and updates directly to your inbox.

Latest News

Ottawa, Alberta agreed to extend $15-a-day child-care fees to 2027

December 12, 2025

Rare footage shows dolphins helping orcas hunt off B.C. coast

December 12, 2025

COMMENTARY: Possible relocation of Wildwood Golf Course is concerning residents

December 12, 2025
Facebook X (Twitter) Pinterest TikTok Instagram
© 2025 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version